WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartman, R. E.
Right arrow Articles by Holtzman, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartman, R. E.
Right arrow Articles by Holtzman, D. M.

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 1, 2002, 22(23):10083-10087

BRIEF COMMUNICATION
Apolipoprotein E4 Influences Amyloid Deposition But Not Cell Loss after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease

Richard E. Hartman1, 2, 3, Helmut Laurer4, Luca Longhi4, Kelly R. Bales5, Steven M. Paul5, 6, Tracy K. McIntosh4, and David M. Holtzman1, 2, 3, 7

1  Center for the Study of Nervous System Injury, 2 Alzheimer's Disease Research Center, 3 Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, 4 Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6316, 5 Neuroscience Discovery Research, Eli Lilly and Company, Lilly Research Laboratories, Indianapolis, Indiana 46285, 6 Department of Pharmacology, Toxicology, and Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46285, and 7 Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110

The epsilon 4 allele of apolipoprotein E (APOE) and traumatic brain injury (TBI) are both risk factors for the development of Alzheimer's disease (AD). These factors may act synergistically, in that APOE4+ individuals are more likely to develop dementia after TBI. Because the mechanism underlying these effects is unclear, we questioned whether APOE4 and TBI interact either through effects on amyloid-beta (Abeta ) or by enhancing cell death/tissue injury. We assessed the effects of TBI in PDAPP mice (transgenic mice that develop AD-like pathology) expressing human APOE3 (PDAPP:E3), human APOE4 (PDAPP:E4), or no APOE (PDAPP:E-/-). Mice were subjected to a unilateral cortical impact injury at 9-10 months of age and allowed to survive for 3 months. Abeta load, hippocampal/cortical volumes, and hippocampal CA3 cell loss were quantified using stereological methods. All of the groups contained mice with Abeta -immunoreactive deposits (56% PDAPP:E4, 20% PDAPP:E3, 75% PDAPP:E-/-), but thioflavine-S-positive Abeta (amyloid) was present only in the molecular layer of the dentate gyrus in the PDAPP:E4 mice (44%). In contrast, our previous studies showed that in the absence of TBI, PDAPP:E3 and PDAPP:E4 mice have little to no Abeta deposition at this age. After TBI, all of the Abeta deposits present in PDAPP:E3 and PDAPP:E-/- mice were diffuse plaques. In contrast to the effect of APOE4 on amyloid, PDAPP:E3, PDAPP:E4, and PDAPP:E-/- mice did not differ in the amount of brain tissue or cell loss. These data support the hypothesis that APOE4 influences the neurodegenerative cascade after TBI via an effect on Abeta .

Key words: Alzheimer's disease; amyloid; APP; traumatic brain injury; apoE; hippocampus


Copyright © 2002 Society for Neuroscience  0270-6474/02/222310083-05$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
H. Belinson, D. Lev, E. Masliah, and D. M. Michaelson
Activation of the Amyloid Cascade in Apolipoprotein E4 Transgenic Mice Induces Lysosomal Activation and Neurodegeneration Resulting in Marked Cognitive Deficits
J. Neurosci., April 30, 2008; 28(18): 4690 - 4701.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
N Nathoo, R Chetty, J R van Dellen, and G H Barnett
Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E
Mol. Pathol., June 1, 2003; 56(3): 132 - 136.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-